More than 4,400 cases have been confirmed as the fastest-growing Ebola outbreak on record strains containment efforts — and scientists race to develop the first approved vaccine targeting the Bundibugyo virus.
The Ebola outbreak in the Democratic Republic of the Congo (DRC) has become the second-largest on record, with the death toll surpassing 2,000 less than three months after the emergency was formally declared.
Government data showed 4,449 confirmed cases and 2,061 deaths as of August 11, according to Reuters. Only the 2014–2016 West Africa epidemic was larger, with more than 28,000 cases and 11,000 deaths.
The current outbreak, declared on May 15, is caused by the comparatively rare Bundibugyo species of Ebola virus. It is also the fastest-growing Ebola outbreak recorded to date, according to UN and international health officials.
The pace has been striking. WHO reported 2,124 confirmed cases and 828 deaths in mid-July, meaning both cases and fatalities have risen sharply in less than a month.
A Critical Gap in Ebola Preparedness
The outbreak is also exposing a major vulnerability in the global Ebola response.
Unlike the Zaire Ebola species responsible for several previous major epidemics, there is currently no approved vaccine or virus-specific treatment for Bundibugyo Ebola.
Scientists are racing to close that gap.
An experimental Moderna vaccine entered its first human trial in Canada this month, involving roughly 80 healthy adults and testing the candidate’s safety and immune response. The Coalition for Epidemic Preparedness Innovations, or CEPI, has committed up to $50 million to support its development and manufacturing.
A separate Bundibugyo-specific vaccine developed by Oxford University and the Serum Institute of India is undergoing an early-stage trial in the United Kingdom, while experimental treatments are also being evaluated in the DRC.
But those efforts will take time. For now, containing transmission still depends heavily on established public-health measures — identifying cases quickly, isolating patients, tracing contacts, ensuring safe burials and maintaining community trust.
Conflict Complicates the Response
Those measures are especially difficult to implement in eastern DRC, where the outbreak is unfolding alongside armed conflict, mass displacement and weak healthcare access.
Health facilities have come under attack amid fear, misinformation and distrust of outside authorities, while insecurity continues to restrict humanitarian access in parts of Ituri province, one of the areas at the centre of the outbreak.
The broader security environment remains volatile. At least 13 civilians were killed and more than 28,000 people displaced following a recent attack in Ituri, according to the UN humanitarian office.
Community transmission is another major concern. WHO has reported that a large share of Ebola deaths are occurring outside treatment facilities, reducing opportunities to isolate patients early and increasing the risk of further transmission through caregiving and burial practices.
Together, insecurity, limited healthcare access and delayed detection are making conventional containment measures harder to sustain at the scale required.
Scientists Investigate the Virus
The outbreak’s unusually rapid growth has also prompted health authorities to investigate whether changes in the virus could be affecting its behaviour.
Africa CDC Director-General Jean Kaseya and WHO Director-General Tedros Adhanom Ghebreyesus have discussed the possibility, but there is currently no established evidence that mutation has made the virus more transmissible.
Separately, recent genomic research found that the outbreak involves a previously unrecorded Bundibugyo variant and most likely originated through a new animal-to-human spillover rather than the re-emergence of an earlier transmission chain.
Whether those genetic differences affect transmissibility or disease severity remains under investigation.
Regional Vigilance Remains High
The outbreak has already demonstrated the potential for regional spread.
Uganda recorded Bundibugyo Ebola cases earlier in the emergency but declared its outbreak over in late July after containing transmission.
Rwanda has not confirmed a Bundibugyo case, but authorities have strengthened surveillance and preparedness because of frequent movement across the border with eastern DRC. WHO and UN partners are supporting healthcare-worker training, screening, protective equipment and community engagement.
The immediate challenge, however, remains inside the DRC.
The outbreak’s rise to become the second-largest in recorded history underscores a difficult reality of epidemic preparedness: scientific tools can advance quickly, but vaccines and treatments still require time to test and deploy. In the meantime, conflict, displacement and fragile health systems can give a fast-moving pathogen critical opportunities to spread.
With more than 4,400 confirmed infections and 2,000 deaths, the central question is whether health authorities can interrupt transmission faster than new chains of infection emerge.
RELATED STORIES:
- Ebola Outbreak Risks Becoming a $3.6 Billion Development Crisis for Africa
- The New Ebola Outbreak Is Exposing a Dangerous Gap in Global Preparedness
- Congo’s Ebola Outbreak Expands Across Five Provinces as WHO Reports Early Signs of Stabilization
- WHO Chief Flies Into Ebola Epicenter as Congo Faces Dangerous Collision of Disease, Conflict, and Global Health Fragmentation
Follow SDG News on LinkedIn
